ITACA NSCLC study: Final results
16 Feb 2021
ITACA NSCLC study: Final results
Renal liposarcoma: Case report and review of systemic treatment
KEYNOTE-598: pembrolizumab with ipilimumab or placebo in patients with untreated metastatic NSCLC
OncoAlert and ecancer weekly roundup for February 01 - 06, 2021
Latest in EGFR-positive NSCLC with exon 20 insertion mutations
WCLC 2020 overview
Escalation and descalation in neoadjuvant time to treatment of TNBC
BRCA mutation in metastatic TNBC patients
OncoAlert and ecancer weekly roundup for January 18 - 24, 2021
OncoAlert and ecancer weekly roundup for January 11 - 17, 2021
The importance of Romanian oncology congress 2020
Why overall survival is still the gold standard end point